SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Matusevicius, D
Right arrow Articles by Link, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matusevicius, D
Right arrow Articles by Link, H
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

D Matusevicius

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

P Kivisäkk

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

B He

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

N Kostulas

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

V Özenci

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

S Fredrikson

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

H Link

Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

Myelin-directed autoimmunity is considered to play a key role in the pathogenesis of multiple sclerosis (MS). Increased production of both pro- and anti-inflammatory cytokines is a common finding in MS. Interleukin-17 (IL-17) is a recently described cytokine produced in humans almost exclusively by activated memory T cells, which can induce the production of proinflammatory cytokines and chemokines from parenchymal cells and macrophages. In situ hybridisation with synthetic oligonucleotide probes was adopted to detect and enumerate IL-17 mRNA expressing mononuclear cells (MNC) in blood and cerebrospinal fluid (CSF) from patients with MS and control individuals. Numbers of IL-17 mRNA expressing blood MNC were higher in patients with MS and acute aseptic meningoencephalitis (AM) compared to healthy individuals. Higher numbers of IL-17 mRNA expressing blood MNC were detected in MS patients examined during clinical exacerbation compared to remission. Patients with MS had higher numbers of IL-17 mRNA expressing MNC in CSF compared to blood. This increase in numbers of IL-17 mRNA expressing MNC in CSF was not observed in patients with AM. Our results thus demonstrate increased numbers of IL-17 mRNA expressing MNC in MS with higher numbers in CSF than blood, and with the highest numbers in blood during clinical exacerbations.

Key Words: IL-17 • multiple sclerosis • aseptic meningoencephalitis • autoimmunity

Multiple Sclerosis, Vol. 5, No. 2, 101-104 (1999)
DOI: 10.1177/135245859900500206


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
E. Nogueira, S. Hamour, D. Sawant, S. Henderson, N. Mansfield, K.-M. Chavele, C. D. Pusey, and A. D. Salama
Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis
Nephrol. Dial. Transplant., January 25, 2010; (2010): gfp783v1 - gfp783.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
L Rovedatti, T Kudo, P Biancheri, M Sarra, C H Knowles, D S Rampton, G R Corazza, G Monteleone, A Di Sabatino, and T T MacDonald
Differential regulation of interleukin 17 and interferon {gamma} production in inflammatory bowel disease
Gut, December 1, 2009; 58(12): 1629 - 1636.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. Brucklacher-Waldert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Brain, December 1, 2009; 132(12): 3329 - 3341.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Shi, M. Ramaswamy, B. P. Vistica, C. A. Cox, C. Tan, E. F. Wawrousek, R. M. Siegel, and I. Gery
Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death
J. Immunol., December 1, 2009; 183(11): 7547 - 7556.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Fletcher, R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, C. O'Farrelly, N. Tubridy, and K. H. G. Mills
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
J. Immunol., December 1, 2009; 183(11): 7602 - 7610.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese
IFN-{beta} Inhibits Human Th17 Cell Differentiation
J. Immunol., October 15, 2009; 183(8): 5418 - 5427.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Bai, N. Lu, Y. Guo, Z. Liu, J. Chen, and Z. Peng
All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis
J. Leukoc. Biol., October 1, 2009; 86(4): 959 - 969.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Annunziato and S. Romagnani
Do studies in humans better depict Th17 cells?
Blood, September 10, 2009; 114(11): 2213 - 2219.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Miossec, T. Korn, and V. K. Kuchroo
Interleukin-17 and Type 17 Helper T Cells
N. Engl. J. Med., August 27, 2009; 361(9): 888 - 898.
[Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. Vojdani and J. Lambert
The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I
Evid. Based Complement. Altern. Med., July 21, 2009; (2009) nep062v1.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Staschke, S. Dong, J. Saha, J. Zhao, N. A. Brooks, D. L. Hepburn, J. Xia, M. F. Gulen, Z. Kang, C. Z. Altuntas, et al.
IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease
J. Immunol., July 1, 2009; 183(1): 568 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. E. McCandless, M. Budde, J. R. Lees, D. Dorsey, E. Lyng, and R. S. Klein
IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2009; 183(1): 613 - 620.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Kivisakk, B. C. Healy, V. Viglietta, F. J. Quintana, M. A. Hootstein, H. L. Weiner, and S. J. Khoury
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
Neurology, June 2, 2009; 72(22): 1922 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Klemann, B. J.E. Raveney, A. K. Klemann, T. Ozawa, S. von Horsten, K. Shudo, S. Oki, and T. Yamamura
Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis
Am. J. Pathol., June 1, 2009; 174(6): 2234 - 2245.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. D. Ooi, R. K.S. Phoon, S. R. Holdsworth, and A. R. Kitching
IL-23, not IL-12, Directs Autoimmunity to the Goodpasture Antigen
J. Am. Soc. Nephrol., May 1, 2009; 20(5): 980 - 989.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Saleh, L. Shan, A. J. Halayko, S. Kung, and A. S. Gounni
Critical Role for STAT3 in IL-17A-Mediated CCL11 Expression in Human Airway Smooth Muscle Cells
J. Immunol., March 15, 2009; 182(6): 3357 - 3365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese
IFN-{beta}1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
J. Immunol., March 15, 2009; 182(6): 3928 - 3936.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F Brentano, C Ospelt, J Stanczyk, R E Gay, S Gay, and D Kyburz
Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis
Ann Rheum Dis, January 1, 2009; 68(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Elliott, A. Metwali, J. Leung, T. Setiawan, A. M. Blum, M. N. Ince, L. E. Bazzone, M. J. Stadecker, J. F. Urban Jr., and J. V. Weinstock
Colonization with Heligmosomoides polygyrus Suppresses Mucosal IL-17 Production
J. Immunol., August 15, 2008; 181(4): 2414 - 2419.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
PNAS, July 8, 2008; 105(27): 9325 - 9330.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Y. Yue, A. Merchant, C. M. Kovacs, M. Loutfy, D. Persad, and M. A. Ostrowski
Virus-Specific Interleukin-17-Producing CD4+ T Cells Are Detectable in Early Human Immunodeficiency Virus Type 1 Infection
J. Virol., July 1, 2008; 82(13): 6767 - 6771.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Serada, M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi, S. Nomura, H. Yoshida, T. Nishikawa, F. Terabe, T. Ohkawara, et al.
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
PNAS, July 1, 2008; 105(26): 9041 - 9046.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Krakauer, P Sorensen, M Khademi, T Olsson, and F Sellebjerg
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-{beta} treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression
Multiple Sclerosis, June 1, 2008; 14(5): 622 - 630.
[Abstract] [PDF]


Home page
J. Immunol.Home page
X. Zhang, J. Jin, X. Peng, V. S. Ramgolam, and S. Markovic-Plese
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
J. Immunol., May 15, 2008; 180(10): 6988 - 6996.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Carlson, M. Kroenke, P. Rao, T. E. Lane, and B. Segal
The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease
J. Exp. Med., April 14, 2008; 205(4): 811 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. Lim, J. Lee, P. Hillsamer, and C. H. Kim
Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells
J. Immunol., January 1, 2008; 180(1): 122 - 129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
Am. J. Pathol., January 1, 2008; 172(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Moisan, R. Grenningloh, E. Bettelli, M. Oukka, and I-C. Ho
Ets-1 is a negative regulator of Th17 differentiation
J. Exp. Med., November 26, 2007; 204(12): 2825 - 2835.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Peng, G. Han, H. Shao, Y. Wang, H. J. Kaplan, and D. Sun
Characterization of IL-17+ Interphotoreceptor Retinoid-Binding Protein-Specific T Cells in Experimental Autoimmune Uveitis
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4153 - 4161.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al.
Phenotypic and functional features of human Th17 cells
J. Exp. Med., August 6, 2007; 204(8): 1849 - 1861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Thakker, M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic
IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis
J. Immunol., February 15, 2007; 178(4): 2589 - 2598.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Gocke, P. D. Cravens, L.-H. Ben, R. Z. Hussain, S. C. Northrop, M. K. Racke, and A. E. Lovett-Racke
T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity
J. Immunol., February 1, 2007; 178(3): 1341 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. H. Hofstetter, K. V. Toyka, M. Tary-Lehmann, and P. V. Lehmann
Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139-151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice
J. Immunol., February 1, 2007; 178(3): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. C. Axtell, L. Xu, S. R. Barnum, and C. Raman
CD5-CK2 Binding/Activation-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Protection Is Associated with Diminished Populations of IL-17-Expressing T Cells in the Central Nervous System
J. Immunol., December 15, 2006; 177(12): 8542 - 8549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Rahman, A. Yamasaki, J. Yang, L. Shan, A. J. Halayko, and A. S. Gounni
IL-17A Induces Eotaxin-1/CC Chemokine Ligand 11 Expression in Human Airway Smooth Muscle Cells: Role of MAPK (Erk1/2, JNK, and p38) Pathways
J. Immunol., September 15, 2006; 177(6): 4064 - 4071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura
IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2006; 177(1): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Lajoie-Kadoch, P. Joubert, S. Letuve, A. J. Halayko, J. G. Martin, A. Soussi-Gounni, and Q. Hamid
TNF-{alpha} and IFN-{gamma} inversely modulate expression of the IL-17E receptor in airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1238 - L1246.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. G. Fallon, S. J. Ballantyne, N. E. Mangan, J. L. Barlow, A. Dasvarma, D. R. Hewett, A. McIlgorm, H. E. Jolin, and A. N.J. McKenzie
Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion
J. Exp. Med., April 17, 2006; 203(4): 1105 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Jenmalm, H. Cherwinski, E. P. Bowman, J. H. Phillips, and J. D. Sedgwick
Regulation of Myeloid Cell Function through the CD200 Receptor
J. Immunol., January 1, 2006; 176(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Ishizu, M. Osoegawa, F.-J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, et al.
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Brain, May 1, 2005; 128(5): 988 - 1002.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
J. Exp. Med., January 18, 2005; 201(2): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. K. Liu, X. Lin, and S. L. Gaffen
Crucial Role for Nuclear Factor of Activated T Cells in T Cell Receptor-mediated Regulation of Human Interleukin-17
J. Biol. Chem., December 10, 2004; 279(50): 52762 - 52771.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Andersson, R. Kokkola, J. Wefer, H. Erlandsson-Harris, and R. A. Harris
Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility
J. Leukoc. Biol., December 1, 2004; 76(6): 1118 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Lieberman, F. Cardillo, A. M. Owyang, D. M. Rennick, D. J. Cua, R. A. Kastelein, and C. A. Hunter
IL-23 Provides a Limited Mechanism of Resistance to Acute Toxoplasmosis in the Absence of IL-12
J. Immunol., August 1, 2004; 173(3): 1887 - 1893.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Ruddy, G. C. Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-{alpha} Is Mediated by CCAAT/Enhancer-binding Protein Family Members
J. Biol. Chem., January 23, 2004; 279(4): 2559 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura
Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice
J. Immunol., December 1, 2003; 171(11): 6173 - 6177.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R.-B. Yang, C. K. D. Ng, S. M. Wasserman, L. G. Komuves, M. E. Gerritsen, and J. N. Topper
A Novel Interleukin-17 Receptor-like Protein Identified in Human Umbilical Vein Endothelial Cells Antagonizes Basic Fibroblast Growth Factor-induced Signaling
J. Biol. Chem., August 29, 2003; 278(35): 33232 - 33238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. W. Hellings, A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens
Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in a Mouse Model of Allergic Asthma
Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 42 - 50.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S Fujino, A Andoh, S Bamba, A Ogawa, K Hata, Y Araki, T Bamba, and Y Fujiyama
Increased expression of interleukin 17 in inflammatory bowel disease
Gut, January 1, 2003; 52(1): 65 - 70.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. R. Kim, R. Manoukian, R. Yeh, S. M. Silbiger, D. M. Danilenko, S. Scully, J. Sun, M. L. DeRose, M. Stolina, D. Chang, et al.
Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production
Blood, September 18, 2002; 100(7): 2330 - 2340.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Benchetrit, A. Ciree, V. Vives, G. Warnier, A. Gey, C. Sautes-Fridman, F. Fossiez, N. Haicheur, W. H. Fridman, and E. Tartour
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism
Blood, March 15, 2002; 99(6): 2114 - 2121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Haudenschild, T. Moseley, L. Rose, and A. H. Reddi
Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer
J. Biol. Chem., February 1, 2002; 277(6): 4309 - 4316.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Starnes, M. J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H. E. Broxmeyer, and R. Hromas
Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production
J. Immunol., October 15, 2001; 167(8): 4137 - 4140.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Infante-Duarte, H. F. Horton, M. C. Byrne, and T. Kamradt
Microbial Lipopeptides Induce the Production of IL-17 in Th Cells
J. Immunol., December 1, 2000; 165(11): 6107 - 6115.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Li, J. Chen, A. Huang, J. Stinson, S. Heldens, J. Foster, P. Dowd, A. L. Gurney, and W. I. Wood
Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family
PNAS, January 18, 2000; 97(2): 773 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lee, W.-H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, et al.
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
J. Biol. Chem., January 5, 2001; 276(2): 1660 - 1664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shi, S. J. Ullrich, J. Zhang, K. Connolly, K. J. Grzegorzewski, M. C. Barber, W. Wang, K. Wathen, V. Hodge, C. L. Fisher, et al.
A Novel Cytokine Receptor-Ligand Pair. IDENTIFICATION, MOLECULAR CHARACTERIZATION, AND IN VIVO IMMUNOMODULATORY ACTIVITY
J. Biol. Chem., June 16, 2000; 275(25): 19167 - 19176.
[Abstract] [Full Text] [PDF]



Advertisement